DM
IFRX icon

Deerfield Management’s InflaRx IFRX Stock Holding History

Deerfield Management’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-88,500
Closed -$2.55M – 119
2018
Q1 		$2.55M Sell
88,500
-86,500
-49% -$2.28M 0.09% 106
2017
Q4 		$3.67M Buy
+175,000
New +$3.16M 0.14% 85

Other funds holding IFRX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deerfield Management's IFRX Position: Q2 2018 in Review

Deerfield Management sold out of InflaRx (IFRX) in Q2 2018, closing a stake of 88,500 shares — an estimated $2.55M sold.

Deerfield Management first reported a position in IFRX in Q4 2017 and held it in 2 quarters. The position peaked at $3.67M in Q4 2017. 34 funds tracked by Wall St. Rank hold IFRX as of Q2 2018.

  • Deerfield Management reported no remaining InflaRx position as of Q2 2018 after selling out during the quarter.
  • Deerfield Management sold 88,500 InflaRx shares in Q2 2018, an estimated $2.55M.
  • Deerfield Management first reported a position in InflaRx in Q4 2017 and held it in 2 quarters.
  • Deerfield Management's InflaRx position peaked at $3.67M in Q4 2017.
  • 34 funds tracked by Wall St. Rank held InflaRx as of Q2 2018.

Based on Deerfield Management's 13F filing for Q2 2018, filed 14 Aug 2018.